Table 5.
Year | Team | Source of stem cells | Model | Observation time | Results |
---|---|---|---|---|---|
2009 | Ganey et al. [73] | Canine ADMSCs + HA | Canine IDD model | 12 months | COL II, proteoglycan content ↑, cell density↑ |
2014 | Marfia et al. [64] | Human ADMSCs | Rat IDD model | 12 weeks | Biglycan content↑, ACAN gene expression↑, imaging signals in IVD↑ |
2018 | Zhou et al. [74] | Human ADMSCs + pig acellular NP scaffold | Rabbit IDD model | 16 weeks | ECM↑, the mechanical properties and biocompatibility of the combination system are brilliant, ADMSCs differentiate into NP cells |
2019 | Ishiguro et al. [75] | Transgenic rat ADMSCs | Rat IDD model without NP | 6 months | Biomechanical properties are maintained in 6 weeks, IVD height maintain, AF and CEPs retain in 6 months |
2019 | Hua et al. [76] | Pretreated human ADMSCs | Rat tail IDD model | 16 weeks | NP-specific markers genes expression and ECM↑, IVD height, water content and ECM content all change |
ADMSCs adipose mesenchymal stem cells, ACAN aggrecan, AF annulus fibrosus, CEPs cartilaginous endplates, COL II collagen type II, ECM extracellular matrix, HA hyaluronic acid, IDD intervertebral disc degeneration, IVD intervertebral disc, NP nucleus pulposus